Pharmacovigilance Market is driven by Increasing Utilization of Artificial Intelligence
![]() |
Pharmacovigilance Market |
Pharmacovigilance
refers to the monitoring of approved drugs and vaccines to detect adverse drug
reactions and identify safety hazards. It encompasses the collection and
interpretation of data from all relevant sources and the prompt communication
of new safety information to health authorities, health care providers and
patients. The rising burden of chronic diseases and increasing consumption of
prescription medicines have fueled the need for effective pharmacovigilance
measures across the world. Growing emphasis on safety issues in clinical trials
is also propelling the demand for pharmacovigilance services. Moreover,
regulatory authorities like FDA have mandated stringent regulations to monitor
the safety of drugs which has boosted the pharmacovigilance market growth.
The global Pharmacovigilance Market is estimated to be valued at US$ 3.59 Bn in
2023 and is expected to exhibit a CAGR of 37.2% over the forecast period 2023
to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends: One of the major trends gaining traction in the
pharmacovigilance market is increasing utilization of artificial intelligence
and machine learning. AI helps in efficient processing of vast amounts of data
generated during drug development and post marketing surveillance. It aids in
detection of unknown adverse drug reactions which often remains unreported.
Machine learning algorithms can analyze huge databases and clinical notes to
identify drug safety patterns. They also support signal detection by comparing
new case reports with historical literature. The integration of AI is allowing
stakeholders to make data-driven decisions, improve safety profiling and risk
management of medications.
Porter's
Analysis
Threat of new entrants: The threat of new entrants is moderate in the
pharmacovigilance market. Entering the market requires significant capital
investments and expertise in regulatory compliance.
Bargaining power of buyers: The bargaining power of buyers is moderate. Buyers
have reasonable choice and switching costs are low as there are several
providers in the market.
Bargaining power of suppliers: The bargaining power of suppliers is low. There
are many suppliers for inputs and outsourcing partners for various services
required in pharmacovigilance.
Threat of new substitutes: There is low threat of substitutes as
pharmacovigilance services are essential to ensure drug safety.
Competitive rivalry: The competitive rivalry is high among existing players to
increase their market share and service offerings.
Key Takeaways
The Global
Pharmacovigilance Market Share is
expected to witness high growth.
Regional
analysis: The North America region dominates the pharmacovigilance market
currently due to stringent regulations. Europe follows North America in terms
of market share due to strong presence of pharmaceutical companies and
outsourcing of pharmacovigilance services. Asia Pacific is expected to grow at
fastest rate during the forecast period with growth in clinical trials and
outsourcing activities to countries like India and China.
Key players operating in the pharmacovigilance market are Collibra NV, SAP SE,
SAS Institute Inc., Symantec Corporation (Norton Lifelock), TIBCO Software
Inc., Informatica Inc., Alation Inc., IBM Corporation, Varonis Systems Inc.,
Alfresco Software Inc., Oracle Corporation, Talend SA and Microsoft
Corporation. Collibra NV provides cloud-based data governance and catalog
software. SAP SE offers intelligent technologies for enterprise data
management.
For more details on the report, Read- https://www.insightprobing.com/pharmacovigilance-market-demand-share-analysis/
Get
more insights on this topic: https://shoutingstars.com/the-rising-future-of-hydrogen-an-eco-friendly-fuel-for-a-greener-tomorrow
Comments
Post a Comment